Clinical Trial Update: Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of the Extracorporeal Liver Assist Device (ELAD) in patients with acute on chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• Extracorporeal Liver Assist Device (ELAD)

Snippet

Sponsor: Vital Therapies, Inc. | Conditions: Acute On Chronic Hepatitis | Phase 2, Phase 3 | Status: COMPLETED